VHL and Hepatic fibrosis: The results showed that injection of Ad-VHL still led to reduced histological fibrosis in BDL- and CCl4-treated mice compared with injection of Ad-Null (Fig. 3D and E), which indicated that VHL overexpression can be therapeutic in mouse models of established liver fibrosis.